FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
◀ COMPAREGIGARESEARCH
HEAD-TO-HEAD

TESAMORELIN VS IPA / CJC-1295

Both are GHRH-axis research compounds, but tesamorelin is FDA-approved (Egrifta®) while CJC-1295 No DAC is research-use only. Tesamorelin is a stabilized GHRH(1-44) · the full natural 44-aa hormone sequence. CJC-1295 No DAC is a GHRH(1-29) analog · the shorter active fragment with stabilizing substitutions. The IPA/CJC-1295 pair adds ghrelin-receptor agonism via ipamorelin.

TESAMORELIN card
A · No. 008
TESAMORELIN

GHRH Analog · Egrifta®

IPA / CJC-1295 card
B · No. 009
IPA / CJC-1295

GH-Secretagogue Pair · Pulsatile

SIDE BY SIDE

FIELD
A · TESAMORELIN
B · IPA / CJC-1295
Parent sequence
GHRH(1-44) · full natural hormone
GHRH(1-29) · active fragment
Length
44 amino acids
29 amino acids (CJC-1295) + 5 amino acids (ipamorelin)
Half-life
~26 min
CJC-1295 No DAC ~30 min · ipamorelin ~2 hr
Receptor engaged
GHRH-R only
GHRH-R (CJC) + GHS-R1a (ipamorelin)
FDA status
Approved (Egrifta®, Egrifta SV®)
Not FDA-approved · research-use only
Approved indication
Reduction of excess abdominal fat in HIV lipodystrophy
None
WADA status
Prohibited at all times (S2)
Prohibited at all times (S2)

WHICH IS BETTER · BY GOAL

FDA-validated visceral-fat researchA · TESAMORELIN

Tesamorelin has the only FDA-approved label for visceral-adipose reduction. Pooled Phase 3 -15.4% VAT at 26 weeks (Falutz 2010 PMID 20554713).

Pulsatile dual-pathway GH activationB · IPA / CJC-1295

IPA/CJC-1295 combines GHRH-receptor + ghrelin-receptor stimulation, producing larger GH pulses via dual-pathway activation. Tesamorelin engages GHRH-R only.

Cost-per-pulse research budgetB · IPA / CJC-1295

Tesamorelin (Egrifta) is expensive at the branded human-prescription level. Research-grade CJC-1295 + ipamorelin is significantly cheaper for laboratory characterization.

STACKING NOTE

Tesamorelin + IPA/CJC-1295 = the GH-Axis Trifecta stack · three complementary upstream regulators of the GH pulse. Combining multiple GH-axis agonists is not supported by published research; the stack is a reference framing rather than a clinical protocol.

SOURCED FROM GIGACOMPOUNDS

Both compounds are available as research-grade material at GigaCompounds · ≥99% purity · per-batch CoA. For laboratory research use only.

SOURCE AT GIGACOMPOUNDS ▶
© 2026 GigaCompounds LLC · For Laboratory Research Use Only